Literature DB >> 12660257

The effect of different hormone therapies on integrin expression and pinopode formation in the human endometrium: a controlled study.

Montserrat Creus1, Jaume Ordi, Francisco Fábregues, Roser Casamitjana, Francisco Carmona, Antonio Cardesa, Juan A Vanrell, Juan Balasch.   

Abstract

BACKGROUND: Integrin expression and pinopode formation have been proposed as a means of distinguishing receptive endometrium from non-receptive in clinical practice, thus offering new directions for the development of contraceptive approaches targeted to the endometrium as well as a better understanding of occult causes of infertility in women. The aim of the present study was to investigate the effect of ovulation induction, oral contraception, treatment with dehydrogesterone, and different regimens of hormone replacement therapy on endometrial alphavbeta3 integrin expression and pinopode formation using a prospective, controlled study design.
METHODS: Histological dating, alphavbeta3 integrin expression and pinopode formation were evaluated in control and treated cycles in six groups of women including eight subjects per group and who received clomiphene citrate, ovarian stimulation for IVF, oral contraception, dehydrogesterone for endometrial luteal phase defect, or two different regimens of hormone replacement therapy. Twelve healthy fertile women served as a general control group.
RESULTS: Alphavbeta3 integrin expression and pinopode formation in the human endometrium were closely related to endometrial maturation as defined by histological dating and this was irrespective of endometria being in-phase or out-of-phase and the hormonal treatment received. Only for clomiphene citrate did a direct effect with reduction in pinopode formation in the midluteal phase seem to exist.
CONCLUSION: Alphavbeta3 integrin expression and pinopode formation in the human endometrium are processes closely related to endometrial maturation and this is irrespective of endometria being in-phase or out-of-phase and the hormonal treatment received. The potential usefulness of those two so-called endometrial markers of implantation as targets for contraceptive approaches or fertility-promoting strategies seems unlikely.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12660257     DOI: 10.1093/humrep/deg177

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  12 in total

1.  Evidence from three cohort studies on the expression of MUC16 around the time of implantation suggests it is an inhibitor of implantation.

Authors:  Liu Liu; Yangyang Wang; Xiaoyan Chen; Yichao Tian; Tin Chiu Li; Lijuan Zhao; Qiaoqiao Chen; Mingling Wei; Songying Zhang
Journal:  J Assist Reprod Genet       Date:  2020-05-02       Impact factor: 3.412

2.  Use of the natural cycle and vitrification thawed blastocyst transfer results in better in-vitro fertilization outcomes : cycle regimens of vitrification thawed blastocyst transfer.

Authors:  Eun Mi Chang; Ji Eun Han; You Shin Kim; Sang Woo Lyu; Woo Sik Lee; Tae Ki Yoon
Journal:  J Assist Reprod Genet       Date:  2011-01-13       Impact factor: 3.412

Review 3.  Pinopodes: Recent advancements, current perspectives, and future directions.

Authors:  Kelsey E Quinn; Brooke C Matson; Margeaux Wetendorf; Kathleen M Caron
Journal:  Mol Cell Endocrinol       Date:  2019-11-15       Impact factor: 4.102

4.  Effect of pretreatment with oral contraceptives and progestins on IVF outcomes in women with polycystic ovary syndrome.

Authors:  Daimin Wei; Yuhua Shi; Jing Li; Ze Wang; Lin Zhang; Yun Sun; Hong Zhou; Yuping Xu; Chunxiang Wu; Ling Liu; Qiongfang Wu; Lili Zhuang; Yanzhi Du; Weiping Li; Heping Zhang; Richard S Legro; Zi-Jiang Chen
Journal:  Hum Reprod       Date:  2016-12-19       Impact factor: 6.918

5.  Optimal Candidates to Do Fresh Embryo Transfer in Those Using Oral Contraceptive Pretreatment in IVF Cycles.

Authors:  Yao Lu; Yichao Niu; Yuan Wang; Yaqiong He; Ying Ding; Xinyuan Lu; Bing Xu; Steven R Lindheim; Yun Sun
Journal:  Front Physiol       Date:  2021-03-11       Impact factor: 4.566

6.  The incidence of aberrant endometrial alphavbeta(3) vitronectin expression in a high risk infertility population: could prolonged GnRH agonist therapy play a role?

Authors:  Eric S Surrey; Debra A Minjarez; William B Schoolcraft
Journal:  J Assist Reprod Genet       Date:  2007-11-17       Impact factor: 3.412

7.  Endometrial pinopode and alphavbeta3 integrin expression is not impaired in infertile patients with endometriosis.

Authors:  Jaume Ordi; Montserrat Creus; Roser Casamitjana; Antonio Cardesa; Juan A Vanrell; Juan Balasch
Journal:  J Assist Reprod Genet       Date:  2003-11       Impact factor: 3.412

8.  Effects of clomiphene citrate plus estradiol or progesterone on endometrial ultrastructure: An RCT.

Authors:  Robabeh Taheripanah; Maryam Kabir-Salmani; Masoomeh Favayedi; Marzieh Zamaniyan; Narges Malih; Anahita Taheripanah
Journal:  Int J Reprod Biomed       Date:  2020-03-29

9.  The endometrial preparation for frozen-thawed euploid blastocyst transfer: a prospective randomized trial comparing clinical results from natural modified cycle and exogenous hormone stimulation with GnRH agonist.

Authors:  Ermanno Greco; Katarzyna Litwicka; Cristiana Arrivi; Maria Teresa Varricchio; Alina Caragia; Alessia Greco; Maria Giulia Minasi; Francesco Fiorentino
Journal:  J Assist Reprod Genet       Date:  2016-05-24       Impact factor: 3.357

10.  Endometrial response to IVF hormonal manipulation: comparative analysis of menopausal, down regulated and natural cycles.

Authors:  Susan M Adams; Vera Terry; Margot J Hosie; Nalini Gayer; Christopher R Murphy
Journal:  Reprod Biol Endocrinol       Date:  2004-04-30       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.